Skip to content

Posterior tibial nerve stimulation and anticholinergic drug solifenacin in patients with overactive bladder

Comparison of the therapeutic effects of posterior tibial nerve stimulation and the anticholinergic drug sulifenacin in patients with hyperactive bladder

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190618043934N25
Enrollment
118
Registered
2024-05-13
Start date
2024-04-20
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder. Overactive bladder

Interventions

Intervention 1: Intervention group: The first intervention group: for 12 weeks, 2 sessions per week and each session for 30 minutes under posterior tibial nerve stimulation treatment and before and af

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Having informed consent to enter the study Passing urine more than 8 times in 24 hours At least 6 months have passed since the onset of symptoms Creating an emergency to urinate, which is accompanied by urgency urinary incontinence

Exclusion criteria

Exclusion criteria: Refusal to continue the plan pregnancy having a history of surgery to treat urinary incontinence treatment with anticholinergic drugs having a urinary tract infection

Design outcomes

Primary

MeasureTime frame
Quality of Life. Timepoint: At the beginning of the study and 3 months after the start of the intervention. Method of measurement: Using a questionnaire to assess the quality of life of patients with lower urinary tract disorders.;Overactive bladder symptoms. Timepoint: At the beginning of the study and 3 months after the start of the intervention. Method of measurement: Using the overactive bladder symptoms evaluation questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZabihullah Mohaghegh

Birjand University of Medical Sciences

oabstudent@gmail.com+98 56 3232 3232

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 19, 2026